GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,469.00p
   
  • Change Today:
    -19.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,293.50p
  • Currency: UK Pounds
  • Shares Issued: 4,129.58m
  • Volume: 1,292,674
  • Market Cap: £60,664m
  • RiskGrade: 129
  • Beta: 0.01

Regulatory News

Transaction in Own Shares 31-Mar-2025 07:00 RNS
Director/PDMR Shareholding 28-Mar-2025 15:30 RNS
Transaction in Own Shares 28-Mar-2025 07:00 RNS
Transaction in Own Shares 27-Mar-2025 07:00 RNS
Transaction in Own Shares 26-Mar-2025 07:00 RNS
GSK uUTI treatment approved by US FDA 25-Mar-2025 16:34 RNS
Transaction in Own Shares 25-Mar-2025 07:00 RNS
Notice of AGM 24-Mar-2025 16:10 RNS
EMA Filing acceptance for Nucala COPD 24-Mar-2025 07:05 RNS
Transaction in Own Shares 24-Mar-2025 07:00 RNS
Director/PDMR Shareholding 21-Mar-2025 15:30 RNS
Transaction in Own Shares 21-Mar-2025 07:00 RNS
Transaction in Own Shares 20-Mar-2025 07:00 RNS
Transaction in Own Shares 19-Mar-2025 07:00 RNS
Transaction in Own Shares 18-Mar-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,469.00p
Change Today -19.50p
% Change -1.31 %
52 Week High 1,812.50p
52 Week Low 1,293.50p
Volume 1,292,674
Shares Issued 4,129.58m
Market Cap £60,664m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Price Trend
2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income
62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 31-Mar-2025

Time Volume / Share Price
11:50 578 @ 1,469.00p
11:50 610 @ 1,469.00p
11:50 6 @ 1,469.00p
11:49 1,616 @ 1,469.00p
11:49 487 @ 1,469.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page